Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...
Steve will be monitoring the Rapid Fires: AI/ML in Bioanalysis session on Monday, Nov. 10, 2025 at 3PM CT at AAPS PharmSci ...
The company aims to bring its technology — a lab-free detection method for cancers, viruses, and bacteria — to market in 2026 ...
The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...
Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, ...
New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), ...
At K 2025, Hans Weber Maschinenfabrik GmbH showcased new developments designed to improve the durability, efficiency and ...
On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...
Every mind-bending molecule in nature has an evolutionary origin; a defense against being eaten, a lure for pollinators, or ...
In addition to DoorDash, the company has partnered with GoPuff to offer same-day delivery in 10 major cities, including New York, San Francisco and Las Vegas.
FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), today announced the launch of its new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback